格雷厄姆高股息低估值战法:年化收益率（1.54%）
本策略精选A股市场中基本面健康、估值合理且具备一定股息收益的优质股票，每月初进行调仓，旨在长期获取稳健收益。
概要
核心指标
- 累计收益率: 26.96%
- 年化收益率: 1.54%
- 基准收益率: 25.62%
- 阿尔法: 0.05
- 夏普比率: 0.16
- 最大回撤: 82.41%
源码
查看AI策略代码
绩效
持仓详情
|
当日收盘价 | 当日市值 | 浮动收益/浮动收益率
|
|||||
|---|---|---|---|---|---|---|---|
| 2026-04-03 | 芭田股份(002170.SZ) | 11.22 | 100 | 102 | 12.53 | 1253 | 131/11.676% |
| 2026-04-03 | 伟星新材(002372.SZ) | 10.525793650794 | 504 | 162 | 10.8 | 5443.2 | 138.2/2.605% |
| 2026-04-03 | 泸州老窖(000568.SZ) | 118.02884615385 | 104 | 162 | 104.27 | 10844.08 | -1430.92/-11.657% |
| 2026-04-03 | 佐力药业(300181.SZ) | 15.163701192454 | 80674 | 466 | 15.51 | 1251253.74 | 27937.31/2.284% |
| 2026-04-02 | 芭田股份(002170.SZ) | 11.22 | 100 | 101 | 12.71 | 1271 | 149/13.28% |
| 2026-04-02 | 伟星新材(002372.SZ) | 10.525793650794 | 504 | 161 | 11.3 | 5695.2 | 390.2/7.355% |
| 2026-04-02 | 泸州老窖(000568.SZ) | 118.02884615385 | 104 | 161 | 105.96 | 11019.84 | -1255.16/-10.225% |
| 2026-04-02 | 佐力药业(300181.SZ) | 15.163701192454 | 80674 | 465 | 16.01 | 1291590.74 | 68274.31/5.581% |
| 2026-04-01 | 芭田股份(002170.SZ) | 11.22 | 100 | 100 | 13 | 1300 | 178/15.865% |
| 2026-04-01 | 伟星新材(002372.SZ) | 10.525793650794 | 504 | 160 | 11.19 | 5639.76 | 334.76/6.31% |
交易详情
| 2026-01-30 | 泸州老窖(000568.SZ) | 买 | 1 | 122.87 | -17.21 | ¥0 | 0 |
| 2025-11-03 | 卫信康(603676.SH) | 卖 | -101 | 11.16 | -1127.16 | ¥6.13 | 92.16 |
| 2025-11-03 | 芭田股份(002170.SZ) | 买 | 100 | 11.17 | 1117 | ¥5 | 0 |
| 2025-10-30 | 伟星新材(002372.SZ) | 买 | 4 | 10.35 | -8.6 | ¥0 | 0 |
| 2025-08-08 | 泸州老窖(000568.SZ) | 买 | 3 | 123.81 | -87.57 | ¥0 | 0 |
| 2025-08-01 | 安科生物(300009.SZ) | 卖 | -1400 | 12.24 | -17136 | ¥22.28 | 5413 |
| 2025-08-01 | 泸州老窖(000568.SZ) | 买 | 100 | 122.7 | 12270 | ¥5 | 0 |
| 2025-08-01 | 伟星新材(002372.SZ) | 买 | 500 | 10.6 | 5300 | ¥5 | 0 |
| 2025-07-01 | 确成股份(605183.SH) | 卖 | -700 | 17.45 | -12215 | ¥17.22 | 1164 |
| 2025-07-01 | 安科生物(300009.SZ) | 买 | 1400 | 8.37 | 11718 | ¥5 | 0 |
